Sermorelin GT 75 mg) recalled over sterility concerns
- Recall date
- November 17, 2016
- Source
- U.S. Food & Drug Administration (FDA) — enforcement report
- Official notice title
- Tri-Coast Pharmacy recalls Sermorelin GT (Sermorelin Acetate 15 mg/GHRP-2 5.4 mg/Theanine (L) 75 mg). Compounded by Tri-Coast Pharmacy
- Recall number
- D-0294-2017
- FDA classification
- Class II
- Brand / firm
- Tri-Coast Pharmacy
- Sold / distributed
- Nationwide
Why it was recalled
Lack of Assurance of Sterility
Class II means using this product may cause temporary or medically reversible health problems; the chance of serious harm is remote.
What was recalled
Sermorelin GT (Sermorelin Acetate 15 mg/GHRP-2 5.4 mg/Theanine (L) 75 mg). Compounded by Tri-Coast Pharmacy
Get recall alerts
Free email alert whenever Tri-Coast Pharmacy has a new recall — straight from official government data. Unsubscribe anytime.
More recalls from: Tri-Coast Pharmacy